Revvity, Inc. is a provider of health science solutions, technologies, and services, which delivers workflows from discovery to development, and diagnosis to cure. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The Life Sciences Segment applications include MicroBeta, The MuviCyte live-cell imaging system, The Signals Image Artist, The VICTOR Nivo multimode plate reader benchtop system, The EnSight multimode plate reader benchtop system, BioLegend LEGENDplex bead-based reagents, and The Quantum GX2 system. We show 7 historical shares outstanding datapoints in our RVTY shares outstanding history coverage, used to compute RVTY market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing RVTY market cap history over the course of time is important for investors
interested in comparing RVTY's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of RVTY versus a peer is one thing; comparing
RVTY market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like RVTY can fluctuate over the course of history.
With this page we aim to empower investors researching RVTY by allowing them to research the RVTY market cap history. |
Free RVTY Email Alerts:
Video: The Importance of Market Cap
